Figure 4.
T2-weighted MR images (top) and ADC maps (bottom) obtained before therapy, during therapy, and at different times posttherapy from one of the mice that received combined oxaliplatin/capecitabine chemoradiation.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.